Predictive value of CA-125 levels in advanced ovarian cancer.


Thirty-eight patients with advanced ovarian cancer were monitored with serial serum CA-125 levels until second-look laparotomy or disease progression. Eleven of 15 patients had normal CA-125 levels but positive findings at second-look operation; two had normal levels despite progression of disease. Normal levels do not reliably predict absence of disease.